Can the Antimicrobial Resistance Benchmark blaze a new trail?

Lancet. 2017 Nov 25;390(10110):2334-2335. doi: 10.1016/S0140-6736(17)32670-3. Epub 2017 Oct 13.

Authors

Jayasree K Iyer¹, Marc Mendelson²

Affiliations

¹ Access to Medicine Foundation, Naritaweg 227-A, 1043 CB, Amsterdam, the Netherlands. Electronic address: jiyer@accesstomedicinefoundation.org.
² Division of Infectious Diseases and HIV Medicine, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.

PMID: 29037525
DOI: 10.1016/S0140-6736(17)32670-3

No abstract available

MeSH terms

Anti-Bacterial Agents / administration & dosage*
Benchmarking*
Drug Resistance, Bacterial / drug effects*
Female
Global Health*
Humans
Male
Prevalence
Risk Assessment
United Nations

Substances

Anti-Bacterial Agents